Amgen バランスシートの健全性
財務の健全性 基準チェック /16
Amgenの総株主資本は$7.5B 、総負債は$60.4Bで、負債比率は802.4%となります。総資産と総負債はそれぞれ$90.9Bと$83.4Bです。 Amgenの EBIT は$6.7Bで、利息カバレッジ比率2.1です。現金および短期投資は$9.0Bです。
主要情報
802.4%
負債資本比率
US$60.40b
負債
| インタレスト・カバレッジ・レシオ | 2.1x |
| 現金 | US$9.01b |
| エクイティ | US$7.53b |
| 負債合計 | US$83.36b |
| 総資産 | US$90.88b |
財務の健全性に関する最新情報
Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26
Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Recent updates
Amgen: A Biotech Giant Offering Value And Growth In A Frothy Market
Nov 03Amgen Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For Next Year
Nov 02Amgen Q3 Earnings Review: So Many Questions, But MariTide Data Top Of The List
Oct 25Amgen: Pipeline Updates, Uplizna Performs And Rocatinlimab Underwhelms
Sep 26Amgen: Growth Is Still A Better Choice
Aug 28Amgen Inc. Just Missed EPS By 46%: Here's What Analysts Think Will Happen Next
Aug 09Amgen: Shows Why Dividend Investing Is Getting Tougher
Aug 07Amgen (NASDAQ:AMGN) Takes On Some Risk With Its Use Of Debt
Jul 26The Price Is Right For Amgen Inc. (NASDAQ:AMGN)
Jul 11Amgen: An Emerging GLP-1 Play, Modest Mid-Teens P/E With Strong Momentum
Jul 05Amgen: You Haven't Seen Anything Yet
Jun 17Amgen Is A Fantastic Dividend Growth Stock With A Weight-Loss Wild Card
Jun 04Amgen Stock: Poised To Break Out (Technical Analysis)
May 21Is Amgen Inc. (NASDAQ:AMGN) Trading At A 41% Discount?
May 04Amgen Stock: Recent Weakness Is Not A Buying Opportunity Yet
May 01Amgen: The Giant With An Impressive Pipeline
Apr 15Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Apr 01Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
Mar 31Amgen Will Benefit From Increased Medical Spending
Mar 12Amgen: A Good Dividend Growth Stock For The Watch List
Mar 04Amgen's (NASDAQ:AMGN) Shareholders May Want To Dig Deeper Than Statutory Profit
Feb 21Pinning Down Amgen Inc.'s (NASDAQ:AMGN) P/E Is Difficult Right Now
Feb 16Amgen: Weight Loss Drug Candidate Debate A Red Herring - Buying The Dip Advisable
Feb 08Amgen: Accelerating The Business And Dividend Growth
Jan 29Is Amgen Inc. (NASDAQ:AMGN) Trading At A 44% Discount?
Jan 29Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks
Jan 22Is Amgen (NASDAQ:AMGN) A Risky Investment?
Dec 28Here's Why Amgen (NASDAQ:AMGN) Has Caught The Eye Of Investors
Dec 13Are Investors Undervaluing Amgen Inc. (NASDAQ:AMGN) By 46%?
Oct 23Is Amgen (NASDAQ:AMGN) Using Too Much Debt?
Sep 22Do Amgen's (NASDAQ:AMGN) Earnings Warrant Your Attention?
Sep 04財務状況分析
短期負債: AMGNの 短期資産 ( $26.8B ) が 短期負債 ( $20.3B ) を超えています。
長期負債: AMGNの短期資産 ( $26.8B ) は 長期負債 ( $63.0B ) をカバーしていません。
デット・ツー・エクイティの歴史と分析
負債レベル: AMGNの 純負債対資本比率 ( 682.7% ) は 高い と見なされます。
負債の削減: AMGNの負債対資本比率は、過去 5 年間で272.6%から802.4%に増加しました。
債務返済能力: AMGNの負債は 営業キャッシュフロー によって 十分にカバーされていません ( 12% )。
インタレストカバレッジ: AMGNの負債に対する 利息支払い は EBIT ( 2.1 x coverage) によって 十分にカバーされていません。